Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Czech Republic16716979.6Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Cyprus16716979.6Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Switzerland16716979.6Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Bulgaria16716979.6Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Belgium16716979.6Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Austria16716979.6Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Albania16716979.6Filed on 2016-03-18
BROADLY NEUTRALIZING, CROSS REACTIVE ANTIBODIES TO HIV-1 Read more about BROADLY NEUTRALIZING, CROSS REACTIVE ANTIBODIES TO HIV-1 US Application 16/718,322Filed on 2019-12-18
Antibody Evolution Immunogens Read more about Antibody Evolution Immunogens Australia2020200453Filed on 2020-01-22
Adaptive Modular Nanoparticle-Based Universal Influenza Vaccine Platform Read more about Adaptive Modular Nanoparticle-Based Universal Influenza Vaccine Platform Patent Cooperation TreatyPCT/US2020/017216Filed on 2020-02-07